A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial

Authors
Newby, LK
Citation
Lk. Newby, A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial, J AM COL C, 36(1), 2000, pp. 319-320
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN journal
07351097 → ACNP
Volume
36
Issue
1
Year of publication
2000
Pages
319 - 320
Database
ISI
SICI code
0735-1097(200007)36:1<319:ARCOSA>2.0.ZU;2-Z